Identification of proteomic biomarkers predicting prostate cancer aggressiveness and lethality despite biopsy-sampling error
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Identification of proteomic biomarkers predicting prostate cancer aggressiveness and lethality despite biopsy-sampling error
Authors
Keywords
-
Journal
BRITISH JOURNAL OF CANCER
Volume 111, Issue 6, Pages 1201-1212
Publisher
Springer Nature
Online
2014-07-18
DOI
10.1038/bjc.2014.396
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2014
- (2014) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Standards for prostate biopsy
- (2014) Marc A. Bjurlin et al. CURRENT OPINION IN UROLOGY
- Overdiagnosis and Overtreatment of Prostate Cancer
- (2014) Stacy Loeb et al. EUROPEAN UROLOGY
- HOXB13, RFX6 and prostate cancer risk
- (2014) Ian G Mills NATURE GENETICS
- Systematic Review: Comparative Effectiveness and Harms of Treatments for Clinically Localized Prostate Cancer
- (2013) Timothy J. Wilt ANNALS OF INTERNAL MEDICINE
- Screening for Prostate Cancer: U.S. Preventive Services Task Force Recommendation Statement
- (2013) Virginia A. Moyer ANNALS OF INTERNAL MEDICINE
- Anchoring proteins encounter mitotic kinases
- (2013) David A. Canton et al. CELL CYCLE
- EAU Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent—Update 2013
- (2013) Axel Heidenreich et al. EUROPEAN UROLOGY
- Validation of a Cell-Cycle Progression Gene Panel to Improve Risk Stratification in a Contemporary Prostatectomy Cohort
- (2013) Matthew R. Cooperberg et al. JOURNAL OF CLINICAL ONCOLOGY
- Population Based Study of Predictors of Adverse Pathology among Candidates for Active Surveillance with Gleason 6 Prostate Cancer
- (2013) Annelies Vellekoop et al. JOURNAL OF UROLOGY
- Validation and clinical utility of prostate cancer biomarkers
- (2013) Howard I. Scher et al. Nature Reviews Clinical Oncology
- MRI-targeted prostate biopsy: a review of technique and results
- (2013) Nicola L. Robertson et al. Nature Reviews Urology
- A Molecular Signature Predictive of Indolent Prostate Cancer
- (2013) S. Irshad et al. Science Translational Medicine
- EZH2, an epigenetic driver of prostate cancer
- (2013) Yeqing Angela Yang et al. Protein & Cell
- Do Adenocarcinomas of the Prostate With Gleason Score (GS)≤6 Have the Potential to Metastasize to Lymph Nodes?
- (2012) Hillary M. Ross et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Prognostic value of a cell cycle progression signature for prostate cancer death in a conservatively managed needle biopsy cohort
- (2012) J Cuzick et al. BRITISH JOURNAL OF CANCER
- The quantitative Gleason score improves prostate cancer risk assessment
- (2012) Adam C. Reese et al. CANCER
- Clonal Progression of Prostate Cancers from Gleason Grade 3 to Grade 4
- (2012) A. G. Sowalsky et al. CANCER RESEARCH
- Telomerase Reactivation following Telomere Dysfunction Yields Murine Prostate Tumors with Bone Metastases
- (2012) Zhihu Ding et al. CELL
- Upgrading and Downgrading of Prostate Cancer from Biopsy to Radical Prostatectomy: Incidence and Predictive Factors Using the Modified Gleason Grading System and Factoring in Tertiary Grades
- (2012) Jonathan I. Epstein et al. EUROPEAN UROLOGY
- Contemporary Grading for Prostate Cancer: Implications for Patient Care
- (2012) Fadi Brimo et al. EUROPEAN UROLOGY
- Gleason Score 6 Adenocarcinoma: Should It Be Labeled As Cancer?
- (2012) H. Ballentine Carter et al. JOURNAL OF CLINICAL ONCOLOGY
- The complexity of prostate cancer: genomic alterations and heterogeneity
- (2012) Lara K. Boyd et al. Nature Reviews Urology
- Frequency and determinants of disagreement and error in gleason scores: A population-based study of prostate cancer
- (2012) Michael Goodman et al. PROSTATE
- Underestimation of Gleason score at prostate biopsy reflects sampling error in lower volume tumours
- (2011) Niall M. Corcoran et al. BJU INTERNATIONAL
- Identification of PHLPP1 as a Tumor Suppressor Reveals the Role of Feedback Activation in PTEN-Mutant Prostate Cancer Progression
- (2011) Muhan Chen et al. CANCER CELL
- Defining and predicting indolent and low risk prostate cancer
- (2011) Chris H. Bangma et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Diagnostic and prognostic molecular biomarkers for prostate cancer
- (2011) Glen Kristiansen HISTOPATHOLOGY
- Changes in Prostate Cancer Grade on Serial Biopsy in Men Undergoing Active Surveillance
- (2011) Sima P. Porten et al. JOURNAL OF CLINICAL ONCOLOGY
- The Potential Impact of Reproducibility of Gleason Grading in Men With Early Stage Prostate Cancer Managed by Active Surveillance: A Multi-Institutional Study
- (2011) Jesse K. McKenney et al. JOURNAL OF UROLOGY
- Prostate Size as a Predictor of Gleason Score Upgrading in Patients With Low Risk Prostate Cancer
- (2011) Judson D. Davies et al. JOURNAL OF UROLOGY
- Hazard of Prostate Cancer Specific Mortality After Radical Prostatectomy
- (2011) Sergey Shikanov et al. JOURNAL OF UROLOGY
- Prognostic value of an RNA expression signature derived from cell cycle proliferation genes in patients with prostate cancer: a retrospective study
- (2011) Jack Cuzick et al. LANCET ONCOLOGY
- SMAD4-dependent barrier constrains prostate cancer growth and metastatic progression
- (2011) Zhihu Ding et al. NATURE
- Cancer genetics-guided discovery of serum biomarker signatures for diagnosis and prognosis of prostate cancer
- (2011) I. Cima et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Molecular classification of prostate cancer using curated expression signatures
- (2011) E. K. Markert et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Prioritizing genes associated with prostate cancer development
- (2010) Ivan P Gorlov et al. BMC CANCER
- Integrative Genomic Profiling of Human Prostate Cancer
- (2010) Barry S. Taylor et al. CANCER CELL
- Time Trends and Local Variation in Primary Treatment of Localized Prostate Cancer
- (2010) Matthew R. Cooperberg et al. JOURNAL OF CLINICAL ONCOLOGY
- TMPRSS2-ERG Gene Fusion Is Not Associated with Outcome in Patients Treated by Prostatectomy
- (2009) Anuradha Gopalan et al. CANCER RESEARCH
- eIF4E Activation Is Commonly Elevated in Advanced Human Prostate Cancers and Significantly Related to Reduced Patient Survival
- (2009) J. R. Graff et al. CANCER RESEARCH
- The Multifaceted Role of MTDH/AEG-1 in Cancer Progression
- (2009) G. Hu et al. CLINICAL CANCER RESEARCH
- Differential expression of apoptotic genes PDIA3 and MAP3K5 distinguishes between low- and high-risk prostate cancer
- (2009) Nicole Pressinotti et al. Molecular Cancer
- Biomarkers for Prostate Cancer
- (2008) Danil V. Makarov et al. Annual Review of Medicine
- Saturation biopsies on autopsied prostates for detecting and characterizing prostate cancer
- (2008) Nicolas B. Delongchamps et al. BJU INTERNATIONAL
- Concordance between Gleason scores of needle biopsies and radical prostatectomy specimens: a population-based study
- (2008) Rune Kvåle et al. BJU INTERNATIONAL
- Gene Panel Model Predictive of Outcome in Men at High-Risk of Systemic Progression and Death From Prostate Cancer After Radical Retropubic Prostatectomy
- (2008) John C. Cheville et al. JOURNAL OF CLINICAL ONCOLOGY
- The Impact of Discordance Between Biopsy and Pathological Gleason Scores on Survival After Radical Prostatectomy
- (2008) Stephen A. Boorjian et al. JOURNAL OF UROLOGY
- A Tissue Biomarker Panel Predicting Systemic Progression after PSA Recurrence Post-Definitive Prostate Cancer Therapy
- (2008) Tohru Nakagawa et al. PLoS One
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started